Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet

Completed · Phase 2 · Has a placebo group

Conditions studied: Lateral Canthal Lines, Crow's Feet

In brief

The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of Crow's Feet.

Key facts

Study ID

NCT01358695

Run by

Anterios Inc.

People needed

111

Starts

2011-05-01

Expected to finish

2012-05-01

Last updated by the study team

2013-07-01

Who can join

Age: 30 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• mild to moderate Crow's Feet wrinkles (IGA 2-3) at rest
• moderate to severe Crow's Feet (IGA 3-4) on contraction
• willingness to refrain from any product affecting skin remodeling
• female subjects must be not pregnant and non-lactating

You may not qualify if…

• history of peri-ocular surgery, brow lift or related procedures
• procedures affecting the lateral canthal region in the prior 12 months
• application of topical prescription medication to the treatment area
• female subjects who are pregnant or are nursing a child

Where it is running

• Total Skin & Beauty Dermatology Center — Birmingham, Alabama, United States
• Baumann Cosmetic & Research Institute — Miami Beach, Florida, United States
• Palm Beach Esthetic Dermatology and Laser Center — West Palm Beach, Florida, United States
• William Coleman III, MD, APMC — Metairie, Louisiana, United States
• Gramercy Park Dermatology — New York, New York, United States
• Cary Skin Care — Cary, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.